STMN4
gene geneOn this page
Also known as RB3
Summary
STMN4 (stathmin 4, HGNC:16078) is a protein-coding gene on chromosome 8p21.2, encoding Stathmin-4 (Q9H169). Exhibits microtubule-destabilizing activity.
Predicted to enable tubulin binding activity. Predicted to be involved in microtubule depolymerization; neuron projection development; and regulation of microtubule polymerization or depolymerization. Predicted to be located in Golgi apparatus and growth cone. Predicted to be active in cytoplasm and neuron projection.
Source: NCBI Gene 81551 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 24 total
- MANE Select transcript:
NM_030795
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16078 |
| Approved symbol | STMN4 |
| Name | stathmin 4 |
| Location | 8p21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RB3 |
| Ensembl gene | ENSG00000015592 |
| Ensembl biotype | protein_coding |
| OMIM | 620740 |
| Entrez | 81551 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 10 protein_coding, 1 retained_intron
ENST00000265770, ENST00000350889, ENST00000519614, ENST00000519997, ENST00000522750, ENST00000522908, ENST00000523048, ENST00000908225, ENST00000908226, ENST00000955363, ENST00000955364
RefSeq mRNA: 10 — MANE Select: NM_030795
NM_001283053, NM_001283054, NM_001283055, NM_001394383, NM_001394384, NM_001394385, NM_001394386, NM_001394387, NM_001394388, NM_030795
CCDS: CCDS6055, CCDS64851, CCDS64852, CCDS64854
Canonical transcript exons
ENST00000350889 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001041541 | 27239971 | 27240162 |
| ENSE00001041546 | 27241054 | 27241262 |
| ENSE00001899075 | 27235308 | 27236905 |
| ENSE00002129297 | 27258351 | 27258404 |
| ENSE00003512503 | 27241677 | 27241757 |
| ENSE00003603937 | 27242397 | 27242492 |
| ENSE00003666498 | 27243711 | 27243801 |
Expression profiles
Bgee: expression breadth ubiquitous, 177 present calls, max score 99.31.
FANTOM5 (CAGE): breadth broad, TPM avg 8.2625 / max 803.8024, expressed in 250 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 92438 | 7.5861 | 240 |
| 92439 | 0.6763 | 129 |
Top tissues by expression
274 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 99.31 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 99.20 | gold quality |
| spinal cord | UBERON:0002240 | 98.89 | gold quality |
| ganglionic eminence | UBERON:0004023 | 98.69 | gold quality |
| prefrontal cortex | UBERON:0000451 | 98.60 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 98.45 | gold quality |
| right frontal lobe | UBERON:0002810 | 98.31 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 98.25 | gold quality |
| frontal cortex | UBERON:0001870 | 98.11 | gold quality |
| frontal lobe | UBERON:0016525 | 98.11 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 98.08 | gold quality |
| hypothalamus | UBERON:0001898 | 98.05 | gold quality |
| neocortex | UBERON:0001950 | 98.04 | gold quality |
| ventricular zone | UBERON:0003053 | 98.00 | gold quality |
| amygdala | UBERON:0001876 | 97.92 | gold quality |
| cerebral cortex | UBERON:0000956 | 97.86 | gold quality |
| primary visual cortex | UBERON:0002436 | 97.84 | gold quality |
| Ammon’s horn | UBERON:0001954 | 97.75 | gold quality |
| cingulate cortex | UBERON:0003027 | 97.73 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 97.73 | gold quality |
| medial globus pallidus | UBERON:0002477 | 97.69 | gold quality |
| globus pallidus | UBERON:0001875 | 97.58 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 97.50 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 97.50 | gold quality |
| occipital lobe | UBERON:0002021 | 97.45 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 97.42 | gold quality |
| telencephalon | UBERON:0001893 | 97.41 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 97.35 | gold quality |
| cerebellar cortex | UBERON:0002129 | 97.30 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 97.29 | gold quality |
Single-cell (SCXA)
Detected in 10 experiment(s), a significant marker in 6.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-11121 | yes | 2539.51 |
| E-MTAB-6911 | yes | 451.51 |
| E-HCAD-5 | yes | 54.08 |
| E-MTAB-7316 | yes | 13.60 |
| E-GEOD-93593 | yes | 10.69 |
| E-HCAD-10 | yes | 5.18 |
| E-MTAB-8894 | no | 1623.43 |
| E-MTAB-9154 | no | 1392.59 |
| E-MTAB-7303 | no | 367.34 |
| E-ANND-3 | no | 2.28 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
64 targeting STMN4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-4671-3P | 99.88 | 72.46 | 1045 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-1197 | 99.70 | 67.75 | 1027 |
| HSA-MIR-7154-5P | 99.69 | 70.52 | 1900 |
| HSA-MIR-6512-3P | 99.65 | 66.07 | 1468 |
| HSA-MIR-6720-5P | 99.65 | 66.22 | 1459 |
| HSA-MIR-488-3P | 99.61 | 68.79 | 1731 |
| HSA-MIR-3682-3P | 99.58 | 67.63 | 865 |
| HSA-MIR-6722-3P | 99.45 | 67.62 | 1919 |
| HSA-MIR-2392 | 99.43 | 67.50 | 708 |
| HSA-MIR-532-3P | 99.34 | 65.76 | 1195 |
| HSA-MIR-4652-3P | 99.33 | 70.02 | 2742 |
| HSA-MIR-6828-5P | 99.31 | 69.21 | 1433 |
| HSA-MIR-3692-5P | 99.29 | 67.04 | 1421 |
| HSA-MIR-4727-5P | 99.23 | 67.55 | 1154 |
| HSA-MIR-122B-3P | 99.21 | 68.90 | 1333 |
| HSA-MIR-21-3P | 99.21 | 68.95 | 1312 |
| HSA-MIR-4279 | 99.19 | 66.70 | 2437 |
| HSA-MIR-6815-3P | 99.13 | 68.98 | 1530 |
| HSA-MIR-4758-3P | 99.12 | 63.96 | 869 |
| HSA-MIR-10524-5P | 99.05 | 66.08 | 963 |
| HSA-MIR-1909-3P | 99.03 | 66.56 | 1662 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | stmn4l | ENSDARG00000043932 |
| mus_musculus | Stmn4 | ENSMUSG00000022044 |
| rattus_norvegicus | Stmn4 | ENSRNOG00000053334 |
| drosophila_melanogaster | stai | FBGN0266521 |
Paralogs (4): STMN2 (ENSG00000104435), STMN1 (ENSG00000117632), STMN3 (ENSG00000197457), STMND1 (ENSG00000230873)
Protein
Protein identifiers
Stathmin-4 — Q9H169 (reviewed: Q9H169)
Alternative names: Stathmin-like protein B3
All UniProt accessions (3): Q9H169, E5RIR6, E7EVN3
UniProt curated annotations — full annotation on UniProt →
Function. Exhibits microtubule-destabilizing activity.
Subcellular location. Golgi apparatus. Cell projection. Growth cone. Axon.
Similarity. Belongs to the stathmin family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H169-1 | 1 | yes |
| Q9H169-2 | 2 | |
| Q9H169-3 | 3 | |
| Q9H169-4 | 4 |
RefSeq proteins (10): NP_001269982, NP_001269983, NP_001269984, NP_001381312, NP_001381313, NP_001381314, NP_001381315, NP_001381316, NP_001381317, NP_110422* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000956 | Stathmin_fam | Family |
| IPR030514 | Stathmin_CS | Conserved_site |
| IPR036002 | Stathmin_sf | Homologous_superfamily |
Pfam: PF00836
UniProt features (15 total): splice variant 3, strand 2, helix 2, lipid moiety-binding region 2, chain 1, domain 1, sequence conflict 1, region of interest 1, coiled-coil region 1, modified residue 1
Structure
Experimental structures (PDB)
10 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9F07 | X-RAY DIFFRACTION | 2.21 |
| 6O5M | X-RAY DIFFRACTION | 2.3 |
| 6BR1 | X-RAY DIFFRACTION | 2.3 |
| 6NNG | X-RAY DIFFRACTION | 2.4 |
| 6BRF | X-RAY DIFFRACTION | 2.5 |
| 7CPD | X-RAY DIFFRACTION | 2.51 |
| 6O61 | X-RAY DIFFRACTION | 2.6 |
| 6PC4 | X-RAY DIFFRACTION | 2.6 |
| 6BRY | X-RAY DIFFRACTION | 2.7 |
| 6O5N | X-RAY DIFFRACTION | 3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H169-F1 | 84.52 | 0.58 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 90, 20, 22
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 130 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN, GNF2_RTN1, GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS, AAGCCAT_MIR135A_MIR135B, GOBP_NEUROGENESIS, GGGTGGRR_PAX4_03, EFC_Q6, CDP_01, chr8p21, GOBP_MICROTUBULE_DEPOLYMERIZATION, NF1_Q6_01, TGCTGAY_UNKNOWN, TGACATY_UNKNOWN, AACTTT_UNKNOWN, GOBP_PROTEIN_DEPOLYMERIZATION
GO Biological Process (3): microtubule depolymerization (GO:0007019), regulation of microtubule polymerization or depolymerization (GO:0031110), neuron projection development (GO:0031175)
GO Molecular Function (2): tubulin binding (GO:0015631), protein binding (GO:0005515)
GO Cellular Component (6): cytoplasm (GO:0005737), Golgi apparatus (GO:0005794), growth cone (GO:0030426), neuron projection (GO:0043005), axon (GO:0030424), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| microtubule polymerization or depolymerization | 2 |
| cellular anatomical structure | 2 |
| protein depolymerization | 1 |
| supramolecular fiber organization | 1 |
| regulation of microtubule cytoskeleton organization | 1 |
| neuron development | 1 |
| plasma membrane bounded cell projection organization | 1 |
| cytoskeletal protein binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| site of polarized growth | 1 |
| distal axon | 1 |
| plasma membrane bounded cell projection | 1 |
| neuron projection | 1 |
Protein interactions and networks
STRING
1860 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| STMN4 | TTL | Q8NG68 | 577 |
| STMN4 | TUBA1B | P04687 | 541 |
| STMN4 | GNG3 | P29798 | 490 |
| STMN4 | FHIP2B | Q86V87 | 459 |
| STMN4 | ACSBG1 | Q96GR2 | 436 |
| STMN4 | SLC32A1 | Q9H598 | 395 |
| STMN4 | SNRPN | P14648 | 369 |
| STMN4 | SLC1A2 | P43004 | 363 |
| STMN4 | ABLIM2 | Q6H8Q1 | 348 |
| STMN4 | RGSL1 | A5PLK6 | 340 |
| STMN4 | TBCA | O75347 | 327 |
| STMN4 | SAXO1 | Q8IYX7 | 302 |
| STMN4 | TUBD1 | Q9UJT1 | 289 |
| STMN4 | KIF9 | Q9HAQ2 | 288 |
| STMN4 | UBE3A | P78355 | 285 |
| STMN4 | CDK5RAP3 | Q96JB5 | 285 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| STMN4 | ANKRD13A | psi-mi:“MI:0915”(physical association) | 0.400 |
| STMN4 | MTNR1B | psi-mi:“MI:0915”(physical association) | 0.370 |
| STMN4 | NUFIP2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MAPT | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| STMN4 | TRAPPC3 | psi-mi:“MI:0914”(association) | 0.350 |
| STMN4 | IMMT | psi-mi:“MI:0915”(physical association) | 0.000 |
| STMN4 | PHIP | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (51): C7orf43 (Affinity Capture-MS), TRAPPC9 (Affinity Capture-MS), TRAPPC6B (Affinity Capture-MS), TRAPPC10 (Affinity Capture-MS), STMN4 (Affinity Capture-MS), TRAPPC4 (Affinity Capture-MS), VTA1 (Affinity Capture-MS), TRAPPC1 (Affinity Capture-MS), TRAPPC3 (Affinity Capture-MS), TRAPPC2 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), PTPRD (Affinity Capture-MS), GCA (Affinity Capture-MS), STMN4 (Two-hybrid), STMN4 (Affinity Capture-Western)
ESM2 similar proteins: A0A088MLT8, A2AQ19, A4FV29, A4IFK9, B3KU38, O14795, O70166, O93388, O95983, P21818, P31395, P50751, P54227, P55821, P63042, P63043, Q09001, Q09002, Q09004, Q09006, Q2KJ58, Q32L68, Q4KUS2, Q4R4N5, Q5F3L9, Q5FVJ5, Q5PSV4, Q5R4C5, Q5R562, Q5R8C6, Q5RAD5, Q62768, Q6GQB5, Q8IVM0, Q8IW50, Q8TBN0, Q8VDV3, Q90987, Q92541, Q93045
Diamond homologs: A4IFK9, A9YWH3, O70166, O93388, P13668, P16949, P21818, P31395, P54227, P55821, P63042, P63043, Q09001, Q09002, Q09004, Q09005, Q09006, Q3T0C7, Q4R4N5, Q4R712, Q5R4C5, Q5R8C6, Q6DUB7, Q90987, Q93045, Q9H169, Q9JHU6, Q9NZ72
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 1 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
852 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:27236901:TTGTC:T | acceptor_gain | 1.0000 |
| 8:27236902:TGTC:T | acceptor_gain | 1.0000 |
| 8:27236903:GTC:G | acceptor_gain | 1.0000 |
| 8:27236904:TC:T | acceptor_gain | 1.0000 |
| 8:27236905:CC:C | acceptor_gain | 1.0000 |
| 8:27236906:C:CC | acceptor_gain | 1.0000 |
| 8:27236906:CT:C | acceptor_loss | 1.0000 |
| 8:27239965:CCTCA:C | donor_loss | 1.0000 |
| 8:27239966:CTCA:C | donor_loss | 1.0000 |
| 8:27239967:TCA:T | donor_loss | 1.0000 |
| 8:27239968:CA:C | donor_loss | 1.0000 |
| 8:27239969:ACCT:A | donor_loss | 1.0000 |
| 8:27239970:CCTT:C | donor_gain | 1.0000 |
| 8:27240012:C:A | donor_gain | 1.0000 |
| 8:27240161:TA:T | acceptor_gain | 1.0000 |
| 8:27240163:C:CC | acceptor_gain | 1.0000 |
| 8:27240163:C:CG | acceptor_loss | 1.0000 |
| 8:27240164:T:C | acceptor_loss | 1.0000 |
| 8:27240172:C:CT | acceptor_gain | 1.0000 |
| 8:27240173:A:AC | acceptor_gain | 1.0000 |
| 8:27240173:A:C | acceptor_gain | 1.0000 |
| 8:27241049:TTTAC:T | donor_loss | 1.0000 |
| 8:27241050:TTAC:T | donor_loss | 1.0000 |
| 8:27241051:TACCT:T | donor_loss | 1.0000 |
| 8:27241052:A:AC | donor_gain | 1.0000 |
| 8:27241052:ACC:A | donor_loss | 1.0000 |
| 8:27241052:ACCTT:A | donor_gain | 1.0000 |
| 8:27241053:C:CC | donor_gain | 1.0000 |
| 8:27241053:CCTT:C | donor_gain | 1.0000 |
| 8:27241053:CCTTC:C | donor_gain | 1.0000 |
AlphaMissense
1433 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:27241180:A:C | F64L | 0.999 |
| 8:27241180:A:T | F64L | 0.999 |
| 8:27241182:A:G | F64L | 0.999 |
| 8:27239981:A:G | L167P | 0.998 |
| 8:27239997:C:G | A162P | 0.998 |
| 8:27240009:C:G | A158P | 0.998 |
| 8:27240060:C:G | A141P | 0.998 |
| 8:27240122:C:G | R120P | 0.998 |
| 8:27241057:C:A | R105S | 0.998 |
| 8:27241057:C:G | R105S | 0.998 |
| 8:27241061:C:G | R104P | 0.998 |
| 8:27241071:C:G | A101P | 0.998 |
| 8:27236883:C:G | R178P | 0.997 |
| 8:27236896:C:G | A174P | 0.997 |
| 8:27239984:C:G | R166P | 0.997 |
| 8:27240000:C:G | A161P | 0.997 |
| 8:27240002:A:G | L160P | 0.997 |
| 8:27240013:C:A | R156S | 0.997 |
| 8:27240013:C:G | R156S | 0.997 |
| 8:27240047:A:G | L145P | 0.997 |
| 8:27240093:C:G | A130P | 0.997 |
| 8:27240143:A:G | L113P | 0.997 |
| 8:27240153:C:G | A110P | 0.997 |
| 8:27241070:G:T | A101D | 0.997 |
| 8:27241074:C:G | A100P | 0.997 |
| 8:27241079:A:G | L98P | 0.997 |
| 8:27241169:A:G | L68P | 0.997 |
| 8:27240134:A:G | L116P | 0.996 |
| 8:27241058:C:G | R105T | 0.996 |
| 8:27241175:A:T | V66D | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000107120 (8:27252363 A>C,G), RS1000145256 (8:27238044 C>T), RS1000145487 (8:27259070 C>G), RS1000160648 (8:27245932 A>G), RS1000382245 (8:27240274 G>A), RS1000409934 (8:27250565 G>A), RS1000452933 (8:27239501 C>T), RS1000477859 (8:27251569 T>C), RS1000505085 (8:27235690 C>A,T), RS1000599610 (8:27235436 T>G), RS1000816636 (8:27240612 T>C), RS1000892163 (8:27246272 G>A), RS1000958623 (8:27251955 C>A), RS1000999853 (8:27256788 T>C), RS1001055044 (8:27241212 C>G,T)
Disease associations
OMIM: gene MIM:620740 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009377_2 | Bone mineral density | 2.000000e-07 |
| GCST009378_11 | Bone mineral content | 7.000000e-07 |
| GCST009378_7 | Bone mineral content | 6.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007620 | volumetric bone mineral density |
| EFO:0007621 | bone mineral content measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, increases expression | 4 |
| Cadmium Chloride | decreases expression, increases expression | 3 |
| Benzo(a)pyrene | increases expression, increases methylation, affects methylation | 2 |
| methylmercuric chloride | decreases expression | 1 |
| arsenite | decreases methylation | 1 |
| mono-(2-ethylhexyl)phthalate | decreases expression | 1 |
| butyraldehyde | increases expression | 1 |
| 15-acetyldeoxynivalenol | increases expression | 1 |
| entinostat | decreases expression | 1 |
| abrine | increases expression | 1 |
| Decitabine | affects expression | 1 |
| Amphotericin B | increases expression | 1 |
| Cisplatin | affects expression | 1 |
| Cytarabine | increases response to substance | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| N-Nitrosopyrrolidine | increases expression | 1 |
| Niclosamide | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.